Erythromycin News and Research

RSS
Erythromycin is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people who have an allergy to penicillins. For respiratory tract infections, it has better coverage of atypical organisms, including mycoplasma and Legionellosis. Erythromycin is an antibiotic produced from a strain of Streptomyces erythraeus.
Experts examine host recognition of Staphylococcus and E.coli bacteria

Experts examine host recognition of Staphylococcus and E.coli bacteria

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Additional data on safety, tolerability of Cempra's solithromycin to be presented at 51st ICAAC

Additional data on safety, tolerability of Cempra's solithromycin to be presented at 51st ICAAC

Biotica, Buck Institute collaborate to investigate polyketides in diseases of aging

Biotica, Buck Institute collaborate to investigate polyketides in diseases of aging

Health Canada approves Bayer's STAXYN for treatment of erectile dysfunction

Health Canada approves Bayer's STAXYN for treatment of erectile dysfunction

Erythromycin can prevent and treat aseptic loosening of total joint replacement

Erythromycin can prevent and treat aseptic loosening of total joint replacement

Biotica acquires full rights to rapamycin analogue program from Pfizer

Biotica acquires full rights to rapamycin analogue program from Pfizer

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

Bacteria that infect cystic fibrosis patients could help combat MRSA

Bacteria that infect cystic fibrosis patients could help combat MRSA

Sugar boosts effectiveness of first-line antibiotics against chronic bacterial infections

Sugar boosts effectiveness of first-line antibiotics against chronic bacterial infections

Inspire reports net loss of $17.6 million for first quarter 2011

Inspire reports net loss of $17.6 million for first quarter 2011

Inspire fourth quarter revenues increase 2% to $30.3 million

Inspire fourth quarter revenues increase 2% to $30.3 million

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Antibiotics with blood pressure medications may cause hypotension

Antibiotics with blood pressure medications may cause hypotension